Paul R Michl
Examiner (ID: 9867)
Most Active Art Unit | 1505 |
Art Unit(s) | 1511, 3502, 1503, 2899, 1714, 1201, 1505, 1506, 3305, 1509 |
Total Applications | 2093 |
Issued Applications | 1688 |
Pending Applications | 51 |
Abandoned Applications | 353 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7193337
[patent_doc_number] => 20040204862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors'
[patent_app_type] => new
[patent_app_number] => 10/411206
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11784
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10411206
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/411206 | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors | Apr 10, 2003 | Abandoned |
Array
(
[id] => 6701458
[patent_doc_number] => 20030224338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Method of generating non-naturally occuring protein models'
[patent_app_type] => new
[patent_app_number] => 10/411839
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8676
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224338.pdf
[firstpage_image] =>[orig_patent_app_number] => 10411839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/411839 | Method of generating non-naturally occuring protein models | Apr 10, 2003 | Abandoned |
Array
(
[id] => 695221
[patent_doc_number] => 07071162
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-04
[patent_title] => 'Combined use of cementum attachment protein and cyclosporin a for improved attachment of dental and orthopedic implants'
[patent_app_type] => utility
[patent_app_number] => 10/410762
[patent_app_country] => US
[patent_app_date] => 2003-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4957
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410762 | Combined use of cementum attachment protein and cyclosporin a for improved attachment of dental and orthopedic implants | Apr 8, 2003 | Issued |
Array
(
[id] => 597059
[patent_doc_number] => 07447595
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-11-04
[patent_title] => 'Heterologous protein production using the twin arginine translocation pathway'
[patent_app_type] => utility
[patent_app_number] => 10/507855
[patent_app_country] => US
[patent_app_date] => 2003-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16447
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/447/07447595.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507855
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507855 | Heterologous protein production using the twin arginine translocation pathway | Mar 16, 2003 | Issued |
Array
(
[id] => 6834312
[patent_doc_number] => 20030161857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Mimetic insect allatostatin analogs for insect control'
[patent_app_type] => new
[patent_app_number] => 10/385317
[patent_app_country] => US
[patent_app_date] => 2003-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8174
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20030161857.pdf
[firstpage_image] =>[orig_patent_app_number] => 10385317
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/385317 | Mimetic insect allatostatin analogs for insect control | Mar 9, 2003 | Issued |
Array
(
[id] => 6825569
[patent_doc_number] => 20030236191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Agent for preventing and/or treating cachexia'
[patent_app_type] => new
[patent_app_number] => 10/382103
[patent_app_country] => US
[patent_app_date] => 2003-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2713
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10382103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/382103 | Agent for preventing and/or treating cachexia | Mar 4, 2003 | Issued |
Array
(
[id] => 625900
[patent_doc_number] => 07139665
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Computational method for designing enzymes for incorporation of non natural amino acids into proteins'
[patent_app_type] => utility
[patent_app_number] => 10/375298
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 34369
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/139/07139665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375298 | Computational method for designing enzymes for incorporation of non natural amino acids into proteins | Feb 26, 2003 | Issued |
Array
(
[id] => 6664744
[patent_doc_number] => 20030204071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => '109 human secreted proteins'
[patent_app_type] => new
[patent_app_number] => 10/372876
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113071
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20030204071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10372876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/372876 | 109 human secreted proteins | Feb 25, 2003 | Abandoned |
Array
(
[id] => 6760878
[patent_doc_number] => 20030124239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Water soluble animal muscle protein product'
[patent_app_type] => new
[patent_app_number] => 10/367026
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5374
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10367026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/367026 | Water soluble animal muscle protein product | Feb 18, 2003 | Abandoned |
Array
(
[id] => 346612
[patent_doc_number] => 07499806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-03
[patent_title] => 'Image processing in microsphere arrays'
[patent_app_type] => utility
[patent_app_number] => 10/504568
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 26375
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/499/07499806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504568 | Image processing in microsphere arrays | Feb 13, 2003 | Issued |
Array
(
[id] => 7677739
[patent_doc_number] => 20040152087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Identification'
[patent_app_type] => new
[patent_app_number] => 10/369193
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6020
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10369193
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/369193 | Identification | Feb 13, 2003 | Abandoned |
Array
(
[id] => 289061
[patent_doc_number] => 07547675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'Chemically modified polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/365418
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10674
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547675.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365418
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365418 | Chemically modified polypeptides | Feb 12, 2003 | Issued |
Array
(
[id] => 6740198
[patent_doc_number] => 20030157567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Oxidised fragments of apolipoprotein B and their use'
[patent_app_type] => new
[patent_app_number] => 10/358594
[patent_app_country] => US
[patent_app_date] => 2003-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2425
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10358594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/358594 | Oxidised fragments of apolipoprotein B and their use | Feb 4, 2003 | Abandoned |
Array
(
[id] => 6731397
[patent_doc_number] => 20030187587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Database'
[patent_app_type] => new
[patent_app_number] => 10/221831
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 31719
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20030187587.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221831 | Database | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7193328
[patent_doc_number] => 20040204861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Evolution-based functional proteomics'
[patent_app_type] => new
[patent_app_number] => 10/349819
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 62810
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10349819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/349819 | Evolution-based functional proteomics | Jan 22, 2003 | Abandoned |
Array
(
[id] => 6835165
[patent_doc_number] => 20030162711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Pharmaceutical formulation'
[patent_app_type] => new
[patent_app_number] => 10/349480
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6908
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 51
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10349480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/349480 | Pharmaceutical formulation | Jan 21, 2003 | Abandoned |
Array
(
[id] => 6804961
[patent_doc_number] => 20030232355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Double-stranded peptide nucleic acids'
[patent_app_type] => new
[patent_app_number] => 10/348246
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6558
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348246
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348246 | Double-stranded peptide nucleic acids | Jan 20, 2003 | Abandoned |
Array
(
[id] => 477356
[patent_doc_number] => 07231301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-12
[patent_title] => 'Method and a system for predicting protein functional site, a method for improving protein function, and a function-modified protein'
[patent_app_type] => utility
[patent_app_number] => 10/345205
[patent_app_country] => US
[patent_app_date] => 2003-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14913
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/231/07231301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10345205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/345205 | Method and a system for predicting protein functional site, a method for improving protein function, and a function-modified protein | Jan 15, 2003 | Issued |
Array
(
[id] => 6856695
[patent_doc_number] => 20030130196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Radiation therapy methods'
[patent_app_type] => new
[patent_app_number] => 10/341001
[patent_app_country] => US
[patent_app_date] => 2003-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 9533
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10341001
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/341001 | Radiation therapy methods | Jan 12, 2003 | Issued |
Array
(
[id] => 6707301
[patent_doc_number] => 20030154035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Simulation of gene expression control using connectrons, interference RNAs (iRNAs) and small temporal RNAs (stRNAs) in prokaryotic, archea and eukaryotic genomes'
[patent_app_type] => new
[patent_app_number] => 10/339666
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 3843
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20030154035.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339666
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339666 | Simulation of gene expression control using connectrons, interference RNAs (iRNAs) and small temporal RNAs (stRNAs) in prokaryotic, archea and eukaryotic genomes | Jan 9, 2003 | Abandoned |